What is the most likely diagnosis for a soft, mobile, non‑tender subcutaneous nodule on the low back of an obese man?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lipoma

A soft, mobile, non-tender subcutaneous nodule on the low back of an obese man is most consistent with a benign lipoma.

Clinical Reasoning

According to the most recent UK guidelines for soft tissue sarcomas, by far the most common soft tissue mass of the limbs and torso seen in primary care is benign lipoma 1. The clinical characteristics described—soft texture, mobility, and lack of tenderness—are classic features of lipomas, which are overwhelmingly the most frequent diagnosis when evaluating subcutaneous masses in this anatomical location.

Key Distinguishing Features

The presentation described has several reassuring characteristics:

  • Soft consistency: Lipomas characteristically feel soft and rubbery, unlike the firm or hard texture that raises concern for malignancy
  • Mobile: Benign lipomas move freely under the skin, whereas malignant masses tend to be fixed to underlying structures
  • Non-tender: The absence of pain is typical for lipomas, though this alone doesn't exclude other diagnoses
  • Location: The low back is a common site for benign lipomas

Important Differential Consideration: "Back Mice"

While lipoma is the most likely diagnosis, it's worth noting that painful subcutaneous nodules in the sacroiliac region near the posterior superior iliac spine are sometimes termed "back mice" (episacroiliac lipomas or fibro-fatty nodules) 2, 3, 4. However, since this patient's nodule is non-tender, this is less likely. Back mice typically present as firm, rubbery, mobile nodules that are painful and occur in characteristic locations near the sacroiliac region 4, 5. Studies show these occur in approximately 25% of adults and are rarely a cause of back pain 6.

When to Pursue Further Evaluation

Consider ultrasound imaging if:

  • The nodule is increasing in size
  • Size is >5 cm
  • Deep-seated location (below the fascia)
  • Any concerning features develop (pain, fixation, firmness)

The 2025 UK guidelines recommend urgent ultrasound (within 2 weeks) for unexplained lumps that are increasing in size 1. Ultrasound can accurately identify superficial lipomas with characteristic features including minimal acoustic shadowing, minimal vascularity, and simple curved echogenic lines within an encapsulated mass 7.

Management Approach

For a typical presentation like this:

  1. Clinical observation is appropriate if the nodule has stable characteristics and the patient is not bothered by it
  2. Reassurance that this is almost certainly benign
  3. No imaging required if clinical examination is consistent with lipoma and there are no red flags
  4. Instruct the patient to return if the nodule enlarges, becomes painful, or changes character

Red Flags Requiring Urgent Evaluation

Refer urgently or obtain imaging if any of these features are present:

  • Size >5 cm
  • Deep location (subfascial)
  • Increasing size
  • Firm or hard consistency
  • Fixed to underlying structures
  • Associated pain (especially if new onset)
  • Overlying skin changes

The distinction between superficial lipomas (which can be managed conservatively) and atypical lipomatous tumors/well-differentiated liposarcomas is critical 1. However, atypical lipomatous tumors tend to be larger, deep-seated, and more common in the lower limb rather than the back 1. MRI with expert review can differentiate these in up to 69% of cases, though definitive diagnosis requires MDM-2 amplification testing on core biopsy 1.

Common Pitfall to Avoid

Do not dismiss all soft tissue masses as "just lipomas" without proper assessment. While most are benign, sarcomas can present as painless masses, and the median size at diagnosis remains large (>9 cm) because of delayed recognition 1. The key is identifying which masses warrant imaging based on size, location, and clinical characteristics rather than imaging every subcutaneous nodule.

Related Questions

What is the likely diagnosis linking persistent headaches, generalized hypotonia, unexplained weight loss, polydipsia, polyuria, increased bowel frequency, brain fog, anxiety, arrhythmia, diffuse muscle weakness, new‑onset hirsutism, recurrent otitis and gastroenteritis, and a childhood acute myositis episode in a 29‑year‑old male?
Why am I experiencing a second menstrual bleed only seven days after my first period with persistent breast tenderness, and what should I do?
What is the differential diagnosis for a 19-year-old woman with 20‑lb unintentional weight loss over 6–8 months despite a reported intake of approximately 1600–1700 kcal per day, regular cardio and weight‑training exercise, no gastrointestinal, constitutional, or other symptoms, and normal routine laboratory tests?
In a 25-year-old woman presenting with fatigue, myalgia, arthralgia, decreased appetite, and alopecia, which laboratory tests should be ordered?
Is a spleen length of 9.6 cm normal in a 41‑year‑old female and does it require further evaluation?
Can a parturient with a footling breech presentation receive a single-shot spinal anesthesia while in the sitting position?
What is the total length of the adult gastrointestinal tract?
In a 66-year-old man with a history of nephrolithiasis treated with lithotripsy, left total hip arthroplasty, hypertension, hyperlipidemia, mild aortic root dilation, mild left ventricular hypertrophy, right bundle branch block on electrocardiogram, and currently taking semaglutide for weight management, who now presents with impaired renal function and hypotension, should a renal ultrasound be performed first or is a non‑contrast computed tomography scan of the abdomen and pelvis required to evaluate the kidneys?
What are the current GINA (Global Initiative for Asthma) guidelines for initiating and stepping up asthma controller therapy?
When is it appropriate to prescribe intravenous iron supplementation for a patient with end‑stage kidney disease (CKD stage 5) who has low serum iron and low ferritin?
What is the most likely adverse effect of medroxyprogesterone therapy in a young female?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.